Please try another search
PT Phapros Tbk, together with its subsidiaries, operates in the pharmaceutical industry in Indonesia. The company operates through Ethical; Over the Counter (OTC) Drugs; Ethical; Generic Drugs Bearing; and Toll-in Manufacturing segments. It offers OTC drugs, including Antimo Anak, Livron B Plek, Noza, Hemorogard, Bioron, and others through pharmacies, retail, and drug stores. The company also provides generic drug products for government institutions and hospitals, as well as produces drugs for other pharmaceutical industries; and offers medical devices, as well as branded/ethical prescription drugs to hospitals, pharmacies, and other healthcare institutions. It operates pharmacies, as well as exports its products. The company was founded in 1954 and is headquartered in Jakarta Selatan, Indonesia. PT Phapros Tbk is a subsidiary of PT Kimia Farma Tbk.
Name | Age | Since | Title |
---|---|---|---|
Masrizal Achmad Syarief | 69 | 2008 | Commissioner |
Chrisma Aryani Albandjar | 51 | 2021 | Independent Commissioner |
Yudhi Rangkuti | - | 2023 | Director of Finance, Risk Management & HR and Director |
Bimo Wijayanto | 45 | 2022 | Independent Commissioner |
Maxi Rein Rondonuwu | 60 | 2021 | President Commissioner |
Maraja Jeson Siregar | - | 2023 | Director of Marketing & Director |
Ida Rahmi Kurniasih | - | 2022 | Acting CEO, Production Director & Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review